US Antimony Corp Files 8-K

TL;DR

US Antimony Corp filed an 8-K on 10/17/25. Check for details.

AI Summary

United States Antimony Corporation filed an 8-K on October 17, 2025, reporting other events and financial statements. The filing does not contain specific details about new material events or financial figures within the provided text.

Why It Matters

This filing indicates a routine update or submission by United States Antimony Corporation to the SEC, which may contain important disclosures for investors.

Risk Assessment

Risk Level: low — The filing is a standard 8-K report without immediate indication of significant negative events.

Key Players & Entities

• UNITED STATES ANTIMONY CORPORATION (company) — Registrant
• October 17, 2025 (date) — Date of earliest event reported
• Texas (jurisdiction) — State of incorporation
• Dallas, TX 75209 (location) — Address of principal executive offices

FAQ

Key Financial Figures

• $0.01 — ange on which registered Common Stock, $0.01 par value UAMY NYSE American Comm
• $400,000,000 — the offer and sale of a total of up to $400,000,000 of shares of the Company's common stock

Filing Documents

• uamy_8k.htm (8-K) — 28KB
• uamy_ex51.htm (EX-5.1) — 20KB
• uamy_ex51img4.jpg (GRAPHIC) — 3KB
• 0001654954-25-011935.txt ( ) — 187KB
• uamy-20251017.xsd (EX-101.SCH) — 5KB
• uamy-20251017_lab.xml (EX-101.LAB) — 16KB
• uamy-20251017_cal.xml (EX-101.CAL) — 1KB
• uamy-20251017_pre.xml (EX-101.PRE) — 12KB
• uamy-20251017_def.xml (EX-101.DEF) — 6KB
• uamy_8k_htm.xml (XML) — 5KB

01 . Other Events

Item 8.01 . Other Events. On October 17, 2025, United States Antimony Corporation (the "Company") filed a prospectus supplement (the "Prospectus Supplement") under the Company's automatic shelf registration statement on Form S-3 (File No. 333-290901) that was originally filed with the Securities and Exchange Commission (the "SEC") on October 16, 2025 and was immediately deemed effective by the SEC (the "Registration Statement"), relating to the offer and sale of a total of up to $400,000,000 of shares of the Company's common stock, par value $0.01 per share (the "Shares"), pursuant to the Amended and Restated Sales Agreement with A.G.P./Alliance Global Partners and B. Riley Securities, Inc. dated September 17, 2025. The opinion of Duane Morris LLP relating to the validity of the Shares offered by the Prospectus Supplement is filed herewith as Exhibit 5.1 to this Current Report on Form 8-K and is incorporated herein by reference. The Shares are registered pursuant to the Registration Statement and the base prospectus contained therein, and offerings for the Shares will be made only by means of the Prospectus Supplement. This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. 2

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 5.1 Opinion of Duane Morris LLP. 23.1 Consent of Duane Morris LLP (included in Exhibit 5.1). 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document). 3

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. UNITED STATES ANTIMONY CORPORATION Dated: October 17, 2025 By: /s/ Richard R. Isaak Richard R. Isaak SVP, Chief Financial Officer 4

View Full Filing

View this 8-K filing on SEC EDGAR